Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial: 60P

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2018-04, Vol.13 (4 Suppl), p.S31-S32
Main Authors: Mathé, Gaston Y, Fogel, P, Martin-Lannerée, S, Marcaillou, C, Lallet, E, Krämer, N, Gibson, N, Solca, F, Ehrnrooth, E, Cadranel, J
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S32
container_issue 4 Suppl
container_start_page S31
container_title Journal of thoracic oncology
container_volume 13
creator Mathé, Gaston Y
Fogel, P
Martin-Lannerée, S
Marcaillou, C
Lallet, E
Krämer, N
Gibson, N
Solca, F
Ehrnrooth, E
Cadranel, J
description
doi_str_mv 10.1016/S1556-0864(18)30336-8
format article
fullrecord <record><control><sourceid>wolterskluwer</sourceid><recordid>TN_cdi_wolterskluwer_health_01243894-201804001-00056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>01243894-201804001-00056</sourcerecordid><originalsourceid>FETCH-wolterskluwer_health_01243894-201804001-000563</originalsourceid><addsrcrecordid>eNqdjM1OAjEUhRujifjzCCZ3CYvqLe1MKjszATSyMICJO3KtHafSGbTtSHgTH9fB8ASuzsnJdz7GrgReCxT5zUJkWc5R56ov9ECilDnXR6z3Nwup8fjQ98gpO4vxA1FlqHSP_RQumNZTcs071G7OpQCKQPAZ7JszyX1bqCmsbYBNCePpZA7LxwdIwVKqbZPAlqUzZHbgGohfLdWbNoKx3oNvO6WhxnTf_qIoBiO4g9i-cmrI76KLe2OqLMyeX_hsD-vO68iPIMenC3ZSko_28pDnTE3Gy-Kebzc-2RDXvt3asKos-VStUAyV1LeKD1FoVIiCI2KWy3_efgEiuGQe</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial: 60P</title><source>ScienceDirect</source><creator>Mathé, Gaston Y ; Fogel, P ; Martin-Lannerée, S ; Marcaillou, C ; Lallet, E ; Krämer, N ; Gibson, N ; Solca, F ; Ehrnrooth, E ; Cadranel, J</creator><creatorcontrib>Mathé, Gaston Y ; Fogel, P ; Martin-Lannerée, S ; Marcaillou, C ; Lallet, E ; Krämer, N ; Gibson, N ; Solca, F ; Ehrnrooth, E ; Cadranel, J</creatorcontrib><identifier>ISSN: 1556-0864</identifier><identifier>EISSN: 1556-1380</identifier><identifier>DOI: 10.1016/S1556-0864(18)30336-8</identifier><language>eng</language><publisher>Copyright by the International Association for the Study of Lung Cancer</publisher><ispartof>Journal of thoracic oncology, 2018-04, Vol.13 (4 Suppl), p.S31-S32</ispartof><rights>Copyright © 2018 by the International Association for the Study of Lung Cancer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mathé, Gaston Y</creatorcontrib><creatorcontrib>Fogel, P</creatorcontrib><creatorcontrib>Martin-Lannerée, S</creatorcontrib><creatorcontrib>Marcaillou, C</creatorcontrib><creatorcontrib>Lallet, E</creatorcontrib><creatorcontrib>Krämer, N</creatorcontrib><creatorcontrib>Gibson, N</creatorcontrib><creatorcontrib>Solca, F</creatorcontrib><creatorcontrib>Ehrnrooth, E</creatorcontrib><creatorcontrib>Cadranel, J</creatorcontrib><title>Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial: 60P</title><title>Journal of thoracic oncology</title><issn>1556-0864</issn><issn>1556-1380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqdjM1OAjEUhRujifjzCCZ3CYvqLe1MKjszATSyMICJO3KtHafSGbTtSHgTH9fB8ASuzsnJdz7GrgReCxT5zUJkWc5R56ov9ECilDnXR6z3Nwup8fjQ98gpO4vxA1FlqHSP_RQumNZTcs071G7OpQCKQPAZ7JszyX1bqCmsbYBNCePpZA7LxwdIwVKqbZPAlqUzZHbgGohfLdWbNoKx3oNvO6WhxnTf_qIoBiO4g9i-cmrI76KLe2OqLMyeX_hsD-vO68iPIMenC3ZSko_28pDnTE3Gy-Kebzc-2RDXvt3asKos-VStUAyV1LeKD1FoVIiCI2KWy3_efgEiuGQe</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Mathé, Gaston Y</creator><creator>Fogel, P</creator><creator>Martin-Lannerée, S</creator><creator>Marcaillou, C</creator><creator>Lallet, E</creator><creator>Krämer, N</creator><creator>Gibson, N</creator><creator>Solca, F</creator><creator>Ehrnrooth, E</creator><creator>Cadranel, J</creator><general>Copyright by the International Association for the Study of Lung Cancer</general><scope/></search><sort><creationdate>201804</creationdate><title>Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial: 60P</title><author>Mathé, Gaston Y ; Fogel, P ; Martin-Lannerée, S ; Marcaillou, C ; Lallet, E ; Krämer, N ; Gibson, N ; Solca, F ; Ehrnrooth, E ; Cadranel, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-wolterskluwer_health_01243894-201804001-000563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mathé, Gaston Y</creatorcontrib><creatorcontrib>Fogel, P</creatorcontrib><creatorcontrib>Martin-Lannerée, S</creatorcontrib><creatorcontrib>Marcaillou, C</creatorcontrib><creatorcontrib>Lallet, E</creatorcontrib><creatorcontrib>Krämer, N</creatorcontrib><creatorcontrib>Gibson, N</creatorcontrib><creatorcontrib>Solca, F</creatorcontrib><creatorcontrib>Ehrnrooth, E</creatorcontrib><creatorcontrib>Cadranel, J</creatorcontrib><jtitle>Journal of thoracic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mathé, Gaston Y</au><au>Fogel, P</au><au>Martin-Lannerée, S</au><au>Marcaillou, C</au><au>Lallet, E</au><au>Krämer, N</au><au>Gibson, N</au><au>Solca, F</au><au>Ehrnrooth, E</au><au>Cadranel, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial: 60P</atitle><jtitle>Journal of thoracic oncology</jtitle><date>2018-04</date><risdate>2018</risdate><volume>13</volume><issue>4 Suppl</issue><spage>S31</spage><epage>S32</epage><pages>S31-S32</pages><issn>1556-0864</issn><eissn>1556-1380</eissn><pub>Copyright by the International Association for the Study of Lung Cancer</pub><doi>10.1016/S1556-0864(18)30336-8</doi></addata></record>
fulltext fulltext
identifier ISSN: 1556-0864
ispartof Journal of thoracic oncology, 2018-04, Vol.13 (4 Suppl), p.S31-S32
issn 1556-0864
1556-1380
language eng
recordid cdi_wolterskluwer_health_01243894-201804001-00056
source ScienceDirect
title Circulating miR-31 as a predictive marker of EGFR TKI treatment efficacy in squamous cell lung cancer (SCC): A sub-analysis of the LUX-Lung 8 trial: 60P
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A58%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20miR-31%20as%20a%20predictive%20marker%20of%20EGFR%20TKI%20treatment%20efficacy%20in%20squamous%20cell%20lung%20cancer%20(SCC):%20A%20sub-analysis%20of%20the%20LUX-Lung%208%20trial:%2060P&rft.jtitle=Journal%20of%20thoracic%20oncology&rft.au=Math%C3%A9,%20Gaston%20Y&rft.date=2018-04&rft.volume=13&rft.issue=4%20Suppl&rft.spage=S31&rft.epage=S32&rft.pages=S31-S32&rft.issn=1556-0864&rft.eissn=1556-1380&rft_id=info:doi/10.1016/S1556-0864(18)30336-8&rft_dat=%3Cwolterskluwer%3E01243894-201804001-00056%3C/wolterskluwer%3E%3Cgrp_id%3Ecdi_FETCH-wolterskluwer_health_01243894-201804001-000563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true